Skip to main content

Advertisement

SpringerLink
Log in

Human alpha and beta herpesviruses and cancer: passengers or foes?

  • Review
  • Published:
Folia Microbiologica Aims and scope Submit manuscript

Abstract

Based on seroepidemiological studies, human herpes simplex virus types 1 and 2 (HSV-1, HSV-2) are put in relation with a number of cancer diseases; however, they do not appear to play a direct role, being only considered cofactors. Their ability to transform the cells in vitro could be demonstrated experimentally by removing their high lytic ability by a certain dose of UV radiation or by photoinactivation in the presence of photosensitizers, such as neutral red or methylene blue, or culturing under conditions suppressing their lytic activity. However, recent studies indicate that UV irradiated or photoinactivated HSV-1 and HSV-2, able to transform non-transformed cells, behave differently in transformed cells suppressing their transformed phenotype. Furthermore, both transforming and transformed phenotype suppressing activities are pertaining only to non-syncytial virus strains. There are some proposed mechanisms explaining their transforming activity. According to the “hit and run” mechanism, viral DNA induces only initiation of transformation by interacting with cellular DNA bringing about mutations and epigenetic changes and is no longer involved in other processes of neoplastic progression. According to the “hijacking” mechanism, virus products in infected cells may activate signalling pathways and thus induce uncontrolled proliferation. Such a product is e.g. a product of HSV-2 gene designated ICP10 that encodes an oncoprotein RR1PK that activates the Ras pathway. In two cases of cancer, in the case of serous ovarian carcinoma and in some prostate tumours, virus-encoded microRNAs (miRNAs) were detected as a possible cofactor in tumorigenesis. And, recently described herpes virus-associated growth factors with transforming and transformation repressing activity might be considered important factors playing a role in tumour formation. And finally, there is a number of evidence that HSV-2 may increase the risk of cervical cancer after infection with human papillomaviruses. A similar situation is with human cytomegalovirus; however, here, a novel mechanism named oncomodulation has been proposed. Oncomodulation means that HCMV infects tumour cells and modulates their malignant properties without having a direct effect on cell transformation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Albrecht T, Rapp F (1973) Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus. Virology 55:53–61

    Article  CAS  PubMed  Google Scholar 

  • Anthony DD, Wentz WB, Reagan JW, Heggie AD (1989) Induction of cervical neoplasia in the mouse by herpes simplex virus type 2 DNA. Proc Natl Acad Sci U S A 86:4520–4524

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Aurelian L (1973) Virions and antigens of herpes virus type 2 in cervical carcinoma. Cancer Res 33:1539–1547

    CAS  PubMed  Google Scholar 

  • Aurelian L (1998) Herpes simplex virus type 2: unique biological properties include neoplastic potential mediated by the PK domain of the large subunit of ribonucleotide reductase. Front Biosci 3:237–249

    Article  Google Scholar 

  • Aurelian L, Standberg JD, Melendez LV et al (1971) Herpes virus type 2 isolated from cervical tumor cells grown in tissue culture. Science 174:704–707

    Article  CAS  PubMed  Google Scholar 

  • Aurelian L, Schumann B, Marcus RL et al (1973) Antibody to HSV-2 induced tumor specific antigens in serums from patients with cervical carcinoma. Science 181:161–164

    Article  CAS  PubMed  Google Scholar 

  • Aurelian L, Kessler II, Rosenheim NB et al (1981) Viruses and gynaecologic cancers: herpes virus protein (ICP10/AG-4), a cervical tumour antigen that fulfils the criteria for a marker of cancerogenity. Cancer 48:455–471

    Article  CAS  PubMed  Google Scholar 

  • Aurelian L, Smith CC, Klacsman KT, Gupta PK, Frost JK (1983) Expression and cellular compartmentalization of a herpes simplex virus type 2 protein (ICP10) in productively infected and cervical tumor cells. Cancer Investig 1:301–313

    Article  CAS  Google Scholar 

  • Bauer G, Kahl S, Sawhney IS, Höfler P, Gerspach R, Matz B (1992) Transformation of rodent fibroblasts by herpes simplex virus: presence of morphological transforming region 1 (MTR1) is not required for the maintenance of the transformed state. Int J Cancer 51:754–760

    Article  CAS  PubMed  Google Scholar 

  • Bender C, Zipeto D, Bidoia C, Costantini S, Zamò A, Menestrina F, Bertazzoni U (2009) Analysis of colorectal cancers for human cytomegalovirus presence. Infect Agents Cancer 4:6. https://doi.org/10.1186/1750-9378-4-6

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bockstahler LE, Coohill TP, Hellman KB et al (1979) Photodynamic therapy for herpes simplex. A critical review. Pharmacol Ther 4:473–499

    Article  CAS  PubMed  Google Scholar 

  • Bosch FX, Lorincz A, Munoz N et al (2002) The casual relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Búda D, Mrázová V, Šupoliková M (2019) Herpes simplex virus type 1 suppress the transformed phenotype of cultured cells. Acta Virol 63:338–340

    Article  CAS  PubMed  Google Scholar 

  • Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16(1):1–17

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Camerom IR, Park M, Dutia BM et al (1985) Herpes simplex virus sequences involved in the initiation of oncogenic morphological transformation of rat cells are not required for maintenance of the transformed state. J Gen Virol 66:517–527

    Article  Google Scholar 

  • Cao S, Gan Y, Dong X et al (2014) Herpes simplex virus type 2 and the risk of cervical cancer: a meta-anylysis of observational studies. Arch Gynecol Obstet 290:1059–1066

    Article  CAS  PubMed  Google Scholar 

  • Carlson JW, Radestad AF, Söderberg-Naucler C et al (2018) Human cytomegalovirus in high grade serous ovarian cancer possible implications for patients survival. Medicine 7(4):e9685

    Article  CAS  Google Scholar 

  • Cassai E, Rotola A, Di Luca D (1981) Herpes simplex virus and human cancer. II. Search for relationship between labial tumours and herpes simplex type 1. Eur J Cancer 17:695–702

    Article  CAS  PubMed  Google Scholar 

  • Činátl J, Scholz M, Kotchetkov R et al (2004) Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology. Trends Mol Med 10:19–23

    Article  CAS  PubMed  Google Scholar 

  • Clure C, Rivard C (2018) Primary herpes simplex virus infection mimicking a cervical malignancy in an immunocompetent individual. Cureus. 10:e2753

    PubMed Central  PubMed  Google Scholar 

  • Cobbs CS (2013) Cytomegalovirus and brain tumor: epidemiology, biology and therapeutic aspects. Curr Opin Oncol 25(6):682–688

    Article  PubMed  Google Scholar 

  • Cobbs CS, Soroceanu L, Denham S et al (2008) Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cancer Res 68:724–730

    Article  CAS  PubMed  Google Scholar 

  • Costa L, Faustino MAF, Neves MG (2012) Photodynamic inactivation of mammalian viruses and bacteriophages. Viruses 4:1034–1074

    Article  PubMed Central  PubMed  Google Scholar 

  • Darai G, Braun R, Flügel RM, Munk K (1977) Malignant transformation of rat embryo fibroblasts by herpes simplex virus types 1 and 2 at suboptimal temperature. Nature 265:744–746

    Article  CAS  PubMed  Google Scholar 

  • Davison AJ, Eberle R, Ehlers B (2009) The order Herpesvirales. Arch Virol 154:171–177

    Article  CAS  PubMed  Google Scholar 

  • Deese J, Pradhan S, Goetz H, Morrison C (2018) Contraceptive use and the risk of sexually transmitted infection: systematic review and current perspectives. Open Access J Contracept 9:91–112

    Article  PubMed Central  PubMed  Google Scholar 

  • Devillers-Mendoza DD, Chang JV (2016) Cytopathologic herpes simplex virus features in laryngeal squamous cell carcinoma. Philipp J Otolaryngol Head Neck Surg 31:61–64

    Article  Google Scholar 

  • Duff R, Rapp F (1971) Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2. J Virol 8:469–477

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • El-Beik T, Razzaque A, Jariwalla R (1986) Multiple transforming regions of human cytomegalovirus DNA. J Virol 60:645–652

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Feldman ER, Tibbetts SA (2015) Emerging roles of herpesvirus microRNAs during in vivo infection and pathogenesis. Curr Pathobiol Rep 3:209–217

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Filippakis H, Spandidos DA, Sourvinos G (2010) Herpesviruses: hijacking the Ras signaling pathway. Biochim Biophys Acta 1803:777–785

    Article  CAS  PubMed  Google Scholar 

  • Freshney RI (2011) Culture of animal cells: a manual of basic technique and specialized applications, 6th edn. Wiley, Hoboken, pp 279–297

    Book  Google Scholar 

  • Friedman JM, Jones PA (2009) MicroRNAs: critical mediators of differentiation, development and disease. Swiss Med Wkly 139:466–472

    CAS  PubMed Central  PubMed  Google Scholar 

  • Galloway DA, McDougall JK (1983) The oncogenic potential of herpes simplex viruses: evidence for a “hit and run” mechanism. Nature 302:21–24

    Article  CAS  PubMed  Google Scholar 

  • Galloway DA, Copple CD, McDougall JK (1980) Anylysis of viral DNA sequences in hamster cells transformed by herpes simplex virus type 2. Proc Natl Acad Sci U S A 77:880–884

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Galloway DA, Nelson JA, McDougall JK (1984) Small fragments of herpesvirus DNA with transforming activity contain insertion sequence-like structures. Proc Natl Acad Sci U S A 81:4736–4740

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Galvan V, Roizman B (1998) Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell type dependent manner. PNAS 95:3931–3936

    Article  CAS  PubMed  Google Scholar 

  • Golais F, Csabayová M, Leško J et al (1992a) Herpes simplex virus type 2 and pseudorabies virus associated growth factors and their role in the latency in vitro. Acta Virol 36:506–515

    Google Scholar 

  • Golais F, Košťál M, Csabayová M et al (1992b) The glycoprotein B gene and its syn3 locus of herpes simplex virus type 1 are involved in the synthesis of virus-associated growth factor (HSGF-1). Acta Virol 36:516–523

    CAS  PubMed  Google Scholar 

  • Goldberg RJ, Gravell M (1976) A search for herpes simplex virus type 2 markers in cervical carcinoma. Cancer Res 36:795–799

    CAS  PubMed  Google Scholar 

  • Grey F (2015) Role of microRNAs in herpesvirus latency and persistence. J Gen Virol 96:739–751

    Article  CAS  PubMed  Google Scholar 

  • Harris TG, Miller L, Kulasingam SL et al (2009) Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection. Am J Obstet Gynecol 200:489.e1–489.e8. https://doi.org/10.1016/j.ajog.2009.01.030

    Article  CAS  Google Scholar 

  • Haverkos H, Rohrer M, Pickworth W (2000) The cause of invasive cervical cancer could be multifactorial. Biomed Pharmacother 54:54–59

    Article  CAS  PubMed  Google Scholar 

  • Hayashi Y, Iwasaka T, Smith CC et al (1986) Multistep transformation by defined fragments of herpes simplex virus type 2 DNA: oncogenic region and its gene products. Proc Natl Acad Sci U S A 82:8493–8497

    Article  Google Scholar 

  • Herbein G (2018) The human cytomegalovirus, from oncomodulation to oncogenesis. Viruses 10:408. https://doi.org/10.3390/v10080408

    Article  CAS  PubMed Central  Google Scholar 

  • Herbein G, Kumar A (2014) The oncogenic potential of human cytomegalovirus and breast cancer. Front Oncol 4:230. https://doi.org/10.3389/fonc.2014.00230

    Article  PubMed Central  PubMed  Google Scholar 

  • Hochhalter CB, Carr CH, O’Neill BE (2017) The association between human cytomegalovirus and glioblastomas: a review. Neuroimmunol Neuroinflammation 4:96–108

    Article  CAS  Google Scholar 

  • Iwasaka T, Smith C, Aurelian L et al (1985) The cervical tumor-associated antigen (ICP10AG4) is encoded by the transforming region of the genome of herpes simplex virus type 2. Jpn J Cancer Res 76:946–958

    CAS  PubMed  Google Scholar 

  • Jain M (2016) Assesment of correlation of herpes simplex virus-1 with oral cancer and precancer-a comparative study. J Clin Diagn Res 10:14–17

    Google Scholar 

  • Jayaraj G, Sherlin HJ, Ramani P (2015) Cytomegalovirus and mucoepidermoid carcinoma: a possible causal relationship? A pilot study. J Oral Maxillofac Pathol 19:319–324

    Article  PubMed Central  PubMed  Google Scholar 

  • Jensen K, Patel A, Larin A et al (2010) Human herpes simplex virus in benign and malignant thyroid tumours. J Pathol 221:193–200

    Article  CAS  PubMed  Google Scholar 

  • Kaur B, Chiocca EA, Cripe TP (2012) Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress. Curr Pharm Biotechnol 13:1842–1851

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kew V, Wills M, Reeves M (2017) HCMV activation of ERK-MAPK drives a multi-factorial response promoting the survival of infected myeloid progenitors. J Mol Biochem 6:13–25

    CAS  PubMed Central  PubMed  Google Scholar 

  • Koanga MML, Ngono RAN, Nganwa G et al (2014) Association of cervical inflammation and cervical abnormalities in women infected with herpes simplex virus type 2. Int J Trop Public Health 4:10–14

    Google Scholar 

  • Kofman A, Marcinkiewicz L, Dupart E et al (2011) The roles of viruses in brain tumor initiation and oncomodulation. J Neuro-Oncol 105:451–466

    Article  Google Scholar 

  • Konvalina I, Gašperík J, Golais F (2002) A novel class of growth factors related to herpesviruses. Acta Vet Brno 71:29–36

    Article  CAS  Google Scholar 

  • Kucera LS, Gudson JP, Edwards I (1977) Oncogenic transformation of rat embryo fibroblasts with photoinactivated herpes simplex virus: rapid in vitro cloning of transformed cells. J Gen Virol 35:473–485

    Article  CAS  PubMed  Google Scholar 

  • Kumari TV, Vasudevan DM, Ankathil R, Ramani P, Vijayakumar T (1987) Demonstration of HSV-1 antigen in patients with oral cancer by immunofluorescence and immunoperoxidase techniques. J Exp Pathol 3:75–86

    CAS  PubMed  Google Scholar 

  • La Thangue NB, Latchman DS (1988) A cellular protein related to heat-shock protein 90 accumulated during herpes simplex virus infection and is overexpressed in transformed cells. Exp Cell Res 178:169–179

    Article  PubMed  Google Scholar 

  • Lehtinen M, Koskela P, Jellum E, Bloigu A, Anttila T, Hallmans G, Luukkaala T, Thoresen S, Youngman L, Dillner J, Hakama M (2002) Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries. Am J Epidemiol 156:687–692

    Article  PubMed  Google Scholar 

  • Levine AJ (2009) The common mechanisms of transformation by the small DNA tumor viruses: the inactivation of tumor suppressor gene products p53. Virology 384:285–293

    Article  CAS  PubMed  Google Scholar 

  • Li JL, Jerkofsky MA, Rapp F (1975) Demonstration of oncogenic potential of mammalian cells by DNA-containing viruses following photodynamic inactivation. Int J Cancer 15:190–202

    Article  CAS  PubMed  Google Scholar 

  • Lie AK, Kristensen G (2008) Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma. Expert Rev Mol Diagn 8:405–415

    Article  CAS  PubMed  Google Scholar 

  • Lowenthal BM, Lin GY (2017) Herpes simplex virus positive, human papillomavirus negative laryngeal squamous cell carcinoma presenting in an immunocompetent male with dysphonia. Hum Pathol 10:50–51

    Google Scholar 

  • Mackowiak PA, Goggans ML, Raese JD et al (1992) Heat-shock protein induction by herpes simplex virus type 1 in MD canine kidney cells. J Therm Biol 17:169–174

    Article  CAS  Google Scholar 

  • Makielski KR, Lee D, Lorenz LD, Nawandar DM, Chiu YF, Kenney SC, Lambert PF (2016) Human papillomavirus promotes Epstein-Barr virus maintenance and lytic reactivation in immortalized oral keratinocytes. Virology 495:52–62

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Marks M, Gravitt PE, Gupta SB, Liaw KL, Tadesse A, Kim E et al (2011) Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from Thailand. J Infect Dis 204:1505–1513

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Marotti J, Aranha AC, De Paula Eduardo C (2009) Photodynamic therapy can be effective as a treatment for herpes simplex labialis. Photomed Laser Surg 27:357–363

    Article  PubMed  Google Scholar 

  • Marotti J, Sperandio FF, Fregnani ER et al (2010) High-intensity laser and photodynamic therapy as a treatment for recurrent herpes labialis. Photomed Laser Surg 28:439–444

    Article  PubMed  Google Scholar 

  • Matis J, Kudelová M (2001) Early shutoff of host protein synthesis in cells infected with herpes simplex viruses. Acta Virol 45:269–277

    CAS  PubMed  Google Scholar 

  • McDougall JK (2001) “Hit and run” transformation leading to carcinogenesis. Dev Biol (Basel) 106:77–82

    CAS  Google Scholar 

  • McDougall JK, Galloway DA, Fenoglio CM (1980) Cervical carcinoma: detection of herpes simplex virus RNA in cells undergoing neoplastic change. Int J Cancer 25:1–8

    Article  CAS  PubMed  Google Scholar 

  • Melnick M, Sedghizadeh PP, Allen CM (2012) Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins are confirmatory of a casual relationship. Exp Mol Pathol 92:118–125

    Article  CAS  PubMed  Google Scholar 

  • Michaelis M, Doerr HW, Činátl J (2009) The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 11:1–9

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Michutová M, Mrázová V, Kudelová M et al (2017) Herpes simplex viruses type 1 and 2 photoinactivated in the presence of methylene blue transform human and mouse cells in vitro. Acta Virol 61:308–315

    Article  CAS  PubMed  Google Scholar 

  • Mistríková J, Rašlová H, Mrmusová M et al (2000) A murine gammaherpesvirus. Acta Virol 44:211–226

    PubMed  Google Scholar 

  • Modrow S, Falke D, Truyen U et al (2010) Molekulare Virologie 3. Aufl. Spektrum Verl.Heidelberg pp 45–52

  • Monjo AL, Pringle ES, Thornbury M (2018) Photodynamic inactivation of herpes simplex viruses. Viruses 10(10):E532. https://doi.org/10.3390/v0532

    Article  PubMed  Google Scholar 

  • Moody CA, Laiminus LA (2010) Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10:550–560

    Article  CAS  PubMed  Google Scholar 

  • Mosunjac M, Park J, Wang W, Tadros T, Siddiqui M, Bagirov M, Little J (2009) Genital and perianal herpes simplex simulating neoplasia in patients with AIDS. AIDS Patient Care STDs 23:153–158

    Article  PubMed  Google Scholar 

  • Mrázová V, Betáková T, Kudelová M et al (2015) Murine gammaherpesvirus (MHV-68) transforms cultured cells in vitro. Intervirology 58:69–72

    Article  CAS  PubMed  Google Scholar 

  • Mrázová V, Kudelová M, Smolinská M et al (2017) Transformation of cells by photoinactivated murine gammaherpesvirus 68 during non-productive and quiescent infection. Intervirology 60:61–68

    Article  CAS  PubMed  Google Scholar 

  • Myers MG, Oxman MN, Clark JF et al (1976) Photodynamic inactivation in recurrent infection with herpes simplex virus. J Infect Dis 133:145–150

    Article  Google Scholar 

  • Nahmias AJ, Naib ZM, Josey WE et al (1973) Perspective studies of the association of genital herpes simplex infection and cervical anaplasia. Cancer Res 33:1491–1497

    CAS  PubMed  Google Scholar 

  • Nash AA, Dutia BM, Stewart JP et al (2001) Natural history of murine gamma-herpesvirus infection. Philos Trans R Soc Lond Ser B Biol Sci 365:569–579

    Article  Google Scholar 

  • Nguyen ML, Blaho AJ (2007) Apoptosis during herpes simplex virus infection. Adv Virus Res 69:67–97

    Article  CAS  PubMed  Google Scholar 

  • Niller HH, Wolf H, Minarovits J (2011) Viral hit and run-oncogenesis: genetic and epigenetic scenarios. Cancer Lett 305:200–217

    Article  CAS  PubMed  Google Scholar 

  • Ortoski RA, Kell CS (2011) Anal cancer and screening guidelines for human papillomavirus in men. J Am Osteopath Ass 111:535–543

    Google Scholar 

  • Osman SAA, Enan KAA, Mohamed EA (2017) Molecular detection of herpes simplex virus (1, 2) in oral squamous cell carcinoma at Khartoum. Clin Med J 3:10–14

    Google Scholar 

  • Pandya D, Mariani M, McHugh M et al (2014) Herpes virus microRNA expression and significance in serous ovarian cancer. PLoS One 9:e114750

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Parker TM, Smith EM, Ritchie JM et al (2006) Head and neck cancer associated with herpes simplex virus 1 and 2 and other risk factors. Oral Oncol 42:288–296

    Article  PubMed  Google Scholar 

  • Perkins D, Pereira EF, Aurelian L (2003) The herpes simplex virus type 2 R1 protein kinase (ICP10PK) fuctions aa a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptic protein Bag-1. J Virol 77:1292–1305

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pfeffer S, Voinnet O (2006) Viruses, microRNAs and cancer. Oncogene 25(46):6211–6219

    Article  CAS  PubMed  Google Scholar 

  • Piedade D, Azevedo-Pereira JM (2016) The role of microRNAs in the pathogenesis of herpesvirus infection. Viruses 8:156

    Article  PubMed Central  CAS  Google Scholar 

  • Quispe Calla NE, Vicetti Miguel RD, Boyaka NP, Hall-Stoodley L et al (2016) Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection. Mucosal Immunol 9:1571–1583

    Article  CAS  PubMed  Google Scholar 

  • Quispe Calla NE, Vicetti Miguel RD, Aceves KM, Torres A (2019) Depot medroxyprogesterone acetate reduces genital cell–cell adhesion molecule expression and increases genital herpes simplex virus type 2 infection susceptibility in a dose-dependent fashion. Contraception 100:397–401

    Article  CAS  PubMed  Google Scholar 

  • Rahman M, Dastmalchi F, Karachi A (2018) The role of CMV in glioblastoma and implications for immunotherapeutic strategies. Oncoimmunology 8:e1514921

    Article  PubMed Central  PubMed  Google Scholar 

  • Raju K (2015) Virus and cervical cancer: role and implication: a review. Biomed Res Ther 2:220–230

    Article  Google Scholar 

  • Ramalho KM, Rocha RG, Correa-Aranha AC, Cunha SR, Simões A, Campos L, Eduardo Cde P (2015) Treatment of herpes simplex labialis in macule and vesicle phases with photodynamic therapy. Report of two cases. Photodiagn Photodyn Ther 12:321–323

    Article  Google Scholar 

  • Ranu H, Lee J, Chio M (2011) Tumour -like presentations of anogenital herpes simplex in HIV-positive patients. Int J STD AIDS 22:181–186

    Article  CAS  PubMed  Google Scholar 

  • Rapp F, Duff R (1973) Transformation of hamster embryo fibroblasts by herpes simplex viruses type 1 and type 2. Cancer Res 33:1527–1534

    CAS  PubMed  Google Scholar 

  • Rapp F, Kemeny BA (1977) Oncogenic potential of herpes simplex virus in mammalian cells following photodynamic inactivation. Photochem Photobiol 25:335–337

    Article  CAS  PubMed  Google Scholar 

  • Reeves MB, Breidenstein A, Compton T (2012) Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells. 109:588–593

  • Reyes GR, LaFemina R, Hayward SD et al (1980) Morphological transformation by DNA fragments of human herpesviruses: evidence for two distinct transforming regions in herpes simplex viruses types 1 and 2 and lack of correlation with biochemical transfer of the thymidine kinase gene. Cold Spring Harb Symp Quant Biol 44:629–641

    Article  CAS  PubMed  Google Scholar 

  • Roizman B, Whitley RJ (2013) An inquiry into the molecular basis of HSV latency and reactivation. Annu Rev Microbiol 67:355–374

    Article  CAS  PubMed  Google Scholar 

  • Roome AP, Tinkler AE, Hilton AL, Montefiore DG, Waller D (1975) Neutral red with photoinactivation in the treatment of herpes genitalis. Br J Vener Dis 51:130–133

    CAS  PubMed Central  PubMed  Google Scholar 

  • Sabin AB, Tarro G (1973) Herpes simplex and herpes genitalis viruses in etiology of some human cancers. Proc Natl Acad Sci U S A 70:3225–3229

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Schnipper LE, Lewin AA, Schwartz M et al (1980) Mechanism of photodynamic inactivation of herpes simplex viruses: comparison between methylene blue, light plus electricity, and hematoporhyrin plus light. J Clin Invest 65:432–438

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Schottstedt V, Blümel J, Burger R et al (2010) Hunan cytomegalovirus (HCMV) revised. Transfus Med Hemother 37:365–375

    Article  PubMed Central  PubMed  Google Scholar 

  • Schwartz MR, Schnipper LE, Lewin AA et al (1979) Inactivation of herpes simplex virus with metlylene blue, light and electricity. Proc Soc Exp Biol Med 61:204–209

    Article  Google Scholar 

  • Sen L, Xi W (2017) Seropositivity to herpes simplex virus type 2, but not type 1 is associated with cervical cancer: NHANES (1999-2014). BMC Cancer 17:726. https://doi.org/10.1186/s12885-017-3734-2

    Article  CAS  Google Scholar 

  • Shen Y, Zhu H, Shenk T (1997) Human cytomegalovirus IE1 and IE2 proteins are mutagenic and mediate “hit and run” oncogenic transaformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci U S A 94:3341–3345

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Shillitoe EJ, Silverman S (1979) Oral cancer and herpes simplex virus-a review. Oral Surg Oral Med Oral Pathol 48:216–224

    Article  CAS  PubMed  Google Scholar 

  • Skeate JG, Porras TB, Woodham AW (2016) Herpes simplex virus downregulation of secretory leucocyte protease inhibitor enhances human papillomavirus type 16 infection. J Gen Virol 97:422–434

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Smith CC (2005) The herpes simplex virus type 2 protein ICP10PK: a master of versatility. Front Biosci 10:2820–2831

    Article  CAS  PubMed  Google Scholar 

  • Smith CC, Aurelian L (1997) The large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is associated with the virion tegument and has PK activity. Virology 234:235–242

    Article  CAS  PubMed  Google Scholar 

  • Smith CC, KulkaM WJP et al (1992) Expression of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for virus growth and neoplastic transformation. J Gen Virol 73:1417–1428

    Article  CAS  PubMed  Google Scholar 

  • Smith CC, Yu YX, Kulka M (2000) A novel human gene similar to the protein kinase (PK) coding domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) codes for a serin-threonine PK and is expressed in melanoma cells. J Biol Chem 275:25690–25699

    Article  CAS  PubMed  Google Scholar 

  • Smith JS, Herrero R, Bosetti C et al (2002) Herpes simplex virus-2 as a papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 94:1604–1613

    Article  CAS  PubMed  Google Scholar 

  • Sorel O, Dewals BG (2016) MicroRNAs in large herpesvirus DNA genomes: recent advances. Biol Mol Concepts 7:229–239

    Article  CAS  Google Scholar 

  • Spandidos DA, Sourvinos G, Tsatsanis C, Zafiropoulos A (2002) Normal ras genes: their Onco-suppressor and pro-apoptotic functions (review). Int J Oncol 21:237–241

    CAS  PubMed  Google Scholar 

  • Sperandio FF, Marotti J, Aranha AC, Eduardo Cde P (2009) Photodynamic therapy for the treatment of recurrent herpes labialis: preliminary results. Gen Dent 57:415–419

    PubMed  Google Scholar 

  • Stamatiou DP, Derdas SP, Zoras OL, Spandidos DA (2016) Herpes and polyoma family viruses in thyroid cancer. Oncol Lett 11:1635–1644

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Starr JR, Daling JR, Fitzgibbons ED, Madeleine MM, Ashley R, Galloway DA, Schwartz SM (2001) Serologic evidence of herpes simplex virus 1 infection and oropharyngeal cancer risk. Cancer Res 61:8459–8464

    CAS  PubMed  Google Scholar 

  • Steele C, Shillitoe EJ (1991) Viruses and oral cancer. Crit Rev Oral Biol Med 2(2):153–175

    Article  CAS  PubMed  Google Scholar 

  • Steiner I, Benninger F (2013) Update on herpes virus infections of the nervous system. Curr Neurol Neurosci Rep 13(12):414

    Article  CAS  PubMed  Google Scholar 

  • Stevenson PG, May JS, Connor V et al (2010) Vaccination againt a “hit and run” viral cancer. J Gen Virol 91:2176–2185

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Šupoliková M, Vojs Staňová A, Kudelová M (2015) Cells transformed by murine herpesvirus 68 (MHV-68) release compound with transforming and transformed phenotype supressing activity resembling growth factors. Acta Virol 59:418–422

    Article  CAS  PubMed  Google Scholar 

  • Suzich JB, Cliffe AR (2018) Strength in diversity: understanding the pathways to herpes simplex virus reactivation. Virology 522:81–91

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sze P, Herman RC (1992) The herpes simplex virus type 1 ICP6 gene is regulated by a “leaky” early promoter. Virus Res 26:141–152

    Article  CAS  PubMed  Google Scholar 

  • Szostek S, Zawilinska B, Kopec J et al (2009) Herpesviruses as possible cofactors in HPV-16 related oncogenesis. Acta Biochim Pol 56:337–342

    Article  CAS  PubMed  Google Scholar 

  • Taher C, de Boniface J, Mohammad AA et al (2013) High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes. PLoS One 8:e56795

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Takahashi M, Yamanishi K (1974) Thansformation of hamster embryo and human embryo cells by temperature sensitive mutants of herpes simplex virus type 2. Virology 61:306–311

    Article  CAS  PubMed  Google Scholar 

  • Tardivo JP, Wainwright M, Baptista MS (2012) Local clinical phototreatment of herpes infection in Sao Paulo. Photodiagn Photodyn Ther 9:118–121

    Article  Google Scholar 

  • Teo WH, Chen HP, Huang JC et al (2017) Human cytomegalovirus infection enhances cell proliferation, migration and upregulation of EMT markers in colorectal cancer-derived stem cell-like cells. Int J Oncol 51:1415–1426

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Thankamani V, Kumari TV, Vasudevan DM (1985) Detection of herpes simplex virus type 2 antigen(s) in biopsies from carcinoma of the uterine cervix. J Exp Pathol 2:123–133

    CAS  PubMed  Google Scholar 

  • Thomas F, Elguero E, Brodeur J (2011) Herpes simplex virus type 2 and cancer: a medical geography approach. Int Genet Evol 11:1239–1242

    Article  Google Scholar 

  • Tomkins A, White C, Higgins SP (2015) Primary herpes simplex virus infection mimicking cervical cancer. BMJ Case Rep bcr2015210194. https://doi.org/10.1136/bcr-2015-210194

    Google Scholar 

  • Turunen A, Hukkanen V, Kulmala J et al (2016) HSV-1 infection modulates the radioresponse of a HPV16 positive head and neck cancer cell line. Anticancer Res 36:565–574

    CAS  PubMed  Google Scholar 

  • Umbach JL, Kramer MF, Jurak I et al (2008) MicroRNAs expressed by herpes simplex virus during latent infection regulate viral mRNAs. Nature 454:780–783

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Valyi-Nagy T, Fredericks B, Ravindra A et al (2018) Herpes simplex virus 1 infection promotes the growth of a subpopulation of tumor cells in three-dimensional uveal melanoma cultures. J Virol 92:e00700–e00718

    Article  PubMed Central  PubMed  Google Scholar 

  • Vonka V, Kanka J, Hirsch I, Závadová H, Krcmár M, Suchánková A, Rezácová D, Broucek J, Press M, Domorázková E (1984) Prospective study on the relationship between cervical neoplasia and herpes simplex type 2 virus. II. Herpes simplex type 2 antibody presence in sera taken at enrollment. Int J Cancer 33:61–66

    Article  CAS  PubMed  Google Scholar 

  • Wang X, Liu S, Zhou Z et al (2017) A herpes simplex virus type 2 encoded microRNA promotes tumor cell metastasis by targeting suppressor of cytokine signaling 2 in lung cancer. Tumour Biol 39:1010428317701633

    PubMed  Google Scholar 

  • Watanabe D, Goshima F (2018) Oncolytic virotherapy by HSV. Adv Exp Med Biol 1045:63–84

    Article  CAS  PubMed  Google Scholar 

  • Wentz WB, Reagan JV, Heggie AD et al (1981) Induction of uterine cancer with inactivated herpes simplex virus types 1 and 2. Cancer 48:1787–1790

    Article  Google Scholar 

  • Yang R, Liang J, Xu GX et al (2018) Human cytomegalovirus glycoprotein B inhibits migration of breast cancer MDA-MB-231 cells and impairs TGF-β/Smad2/3 expression. Oncol Lett 15:7730–7738

    PubMed Central  PubMed  Google Scholar 

  • Yen GSL, Simon EH (1978) Photosenzitization of herpes simplex virus type 1 with neutral red. J Gen Virol 41:273–281

    Article  CAS  PubMed  Google Scholar 

  • Ypiranga S, de Moraes AM (2009) Prevalence of herpes virus type 1 in epithelial skin cancer. Ann Bras Dermatol 84:137–142

    Article  Google Scholar 

  • Yun SJ, Jeong P, Kang HW et al (2015) Urinary microRNAs of prostate cancer: virus encoded hsv1-miR-H18 and hsv2-miR-H9-5p could be valuable diagnostic markers. Int Neurourol J 19:74–84

    Article  PubMed Central  PubMed  Google Scholar 

  • Yun SJ, Jeong P, Kang HW et al (2016) Enhanced expression of herpes virus encoded hsv1-miR-H18 and hsv2-miR-H9-5p in cancer-containing prostate tissue compared to that in benign prostate hyperplasia tissue. Int Neurourol 20(2):122–130

    Article  Google Scholar 

  • Zhao Y, Cao X, Tang J, Zhou L, Gao Y, Wang J, Zheng Y, Yin S, Wang Y (2012) A novel multiplex real-time PCR assay for the detection and quantification of HPV16/18 and HSV1/2 in cervical cancer screening. Mol Cell Probes 26:66–72

    Article  CAS  PubMed  Google Scholar 

  • Zhu Y, Haecker I, Yang Y (2013) γ-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis. Curr Opin Virol 3:266–275

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was supported by the joint grant agency of the Slovak Ministry of Education and Slovak Academy of Sciences VEGA no. 1/0061/18 and by the Slovak Research and Development Agency APVV-0621-12.

Author information

Authors and Affiliations

  1. Faculty of Natural Sciences, Department of Microbiology and Virology, Comenius University, Ilkovičová 6, 842 15, Bratislava, Slovakia

    František Golais

  2. St Elizabeth Cancer Institute Heyduková 10, Heyduková 10, 812 50, Bratislava, Slovakia

    Veronika Mrázová

Authors
  1. František Golais
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Veronika Mrázová
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to František Golais.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Golais, F., Mrázová, V. Human alpha and beta herpesviruses and cancer: passengers or foes?. Folia Microbiol 65, 439–449 (2020). https://doi.org/10.1007/s12223-020-00780-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12223-020-00780-x

Search

Navigation